Bristol-Myers Squibb CompanyBMYNYSE
Loading
EV to Sales HistoryFair Value
Percentile Rank14
3Y CAGR-8.7%
5Y CAGR-6.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-8.7%/yr
vs +1.4%/yr prior
5Y CAGR
-6.0%/yr
Consistent
Acceleration
-10.1pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.05 | -5.2% |
| 2024 | 3.22 | +6.4% |
| 2023 | 3.03 | -24.5% |
| 2022 | 4.00 | +9.2% |
| 2021 | 3.67 | -12.0% |
| 2020 | 4.17 | -24.7% |
| 2019 | 5.53 | +46.3% |
| 2018 | 3.78 | -24.0% |
| 2017 | 4.97 | -3.5% |
| 2016 | 5.15 | - |